In line with this evidence, no measurable IFN-β and low levels of IFN-α and ISGs were associated with a higher blood viral load and inflammatory response in sera of severe and critical COVID-19 patients as compared to mild cases [36] (Figure 2). This evidence concerns the gene IFNA1 and COVID-19.